Browsing by Author "Maity R."

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Dinuclear platinum(ii) complexes with biphenyl-based bis-carbene ligands
    (Royal Society of Chemistry, 2024) Naskar R.; Mondal B.; Sengupta D.; Ghosh A.; Garai S.; Maity R.
    Multimetallic NHC (N-heterocyclic carbene) complexes comprising platinum(ii) centers are rare. Four new dinuclear platinum(ii) complexes possessing a combination of NHC and Py/4-Cl(Py) ligands are presented. Both classical and mesoionic carbene (MIC) ligands have been employed for the complexation. All complexes have been characterized using standard spectroscopic tools. The coordination of both classical NHC and pyridine ligands around the platinum(ii) center in complex [2] has been established by using single crystal XRD. � 2024 The Royal Society of Chemistry.
  • Thumbnail Image
    Item
    Synthesis of an Aryl-Semicarbazone-Based Cu(II) Complex for DNA and BSA Interaction and Anti-Cancer Activity against Human Cervix Uteri Carcinoma
    (Multidisciplinary Digital Publishing Institute (MDPI), 2024) Maity R.; Manna B.; Maity S.; Jana K.; Maity T.; Afzal M.; Sepay N.; Samanta B.C.
    The current study provides an in-depth analysis of the biological properties of a Cu(II) complex (C22H24Cu2N6O10) obtained from an aryl-semicarbazone ligand derived (L) from the condensation of 2,4-dihydroxy acetophenone and semicarbazide. The binding behavior of this complex with calf thymus DNA (CT-DNA) and bovine serum albumin (BSA) protein was explored using a combination of experimental and theoretical approaches. The results suggest that the complex binds with CT-DNA via a partial intercalation, and hydrophobic interaction. However, the complex binds to BSA protein predominantly through hydrogen bonding or van der Waals interactions rather than hydrophobic interactions. The molecular docking methodology was carried out to substantiate the experimental finding. Furthermore, the in vitro cytotoxicity study was conducted on human cervix uteri carcinoma (SiHa cancerous cell) lines upon exposure to the complex, and the findings reveal a considerable decrease in cell viability, when compared to the control. Overall, this study provides a comprehensive understanding of the biological potential of the Cu(II) complex and its potential as an anti-cancer agent. � 2024 by the authors.
  • Thumbnail Image
    Item
    Tetranuclear PdII Complexes Containing an Adamantane-Based Tetra-MIC Ligand: Ancillary-Ligand-Dependent Catalytic and Redox Activities
    (American Chemical Society, 2024) Mondal B.; Naskar R.; Bag J.; Garai S.; Maity R.
    The novel tetra-triazolium salt 1, featuring a tetrasubstituted central adamantane backbone, is introduced for the synthesis of tetranuclear PdII MIC complexes by quadruple C5-H deprotonation and subsequent addition of the corresponding PdII precursors. The three newly prepared palladium(II) complexes appeared to be stable and have been characterized using standard spectroscopic and HRMS techniques. The molecular structure of the tetranuclear PdII complex bearing a 4-methoxypyridine ligand has been established by using single-crystal XRD. All three newly prepared tetranuclear PdII complexes appeared as active precatalysts for the Sonogashira coupling reaction, which occurred in a homogeneous fashion; however, only the palladium(II) complex bearing a combination of MIC and phosphine ligands was found to be active for the intermolecular ?-arylation of 1-methyl-2-oxindole, as the complexes bearing a pyridine or a 4-methoxypyridine ligand decomposed to Pd0 NPs and appeared to be inactive in the ?-arylation reaction. The ancillary-ligand-dependent (Py vs PPh3) interplay between homogeneous and heterogeneous catalyses has also been correlated with the catalytic outcomes in ?-arylation of 1-methyl-2-oxindole. The electrochemical responses of these complexes have been measured, and the effect of ancillary ligands in both electrochemistry and catalysis has also been examined. � 2024 American Chemical Society.